Table 4 ROC curve AUCs for three-biomarker model at two time-points
From: Biomarker profiling for risk of future heart failure (HFpEF) development
Excluding Meds | Including Meds | IDI [95% CI]* | NRI [95% CI]*† | |||
|---|---|---|---|---|---|---|
AUC [95% CI] | Tjur R2 | AUC [95% CI] | Tjur R2 | |||
Baseline data | 0.79 [0.69,0.88] | 22.9% | 0.80 [0.71,0.89] | 28.4% | 5.4 [0.3,10.4] | 5.0 [− 13.3,23.3] |
Follow-up data | 0.85 [0.77,0.93] | 30.0% | 0.86 [0.78,0.93] | 36.3% | 6.2 [0.6,11.8] | 11.8 [− 4.9,28.6] |